Catalog Advanced Search
-
Contains 41 Component(s)
A 20-hour on-demand course for APPs in sleep clinics to expand their knowledge of sleep medicine. The course overviews sleep science, sleep technology, patient evaluation, and a range of sleep disorders. Log into your World Sleep Society account to view for free!
Overview
Online self-guided course aimed at advanced practice providers who want to expand their knowledge of sleep medicine. Over 20 hours of content covers a broad range of sleep medicine topics from experts in the field. The presentations were previously recorded during the World Sleep Academy.
Target Audience
The course is aimed at Advanced Practice Providers (APPs), including nurse practitioners, physician assistants, clinical nurse specialists, and other licensed healthcare professionals in sleep.
Course Contents
The course includes the following modules:
1. Basic Sleep Science
2. Sleep Technology
3. Patient Screening and Assessment
4. Insomnia
5. Circadian Rhythm Sleep-Wake Disorders
6. Sleep-Related Movement Disorders
7. Parasomnias
8. Hypersomnias
9. Sleep-Related Breathing Disorders
10. Pediatric Sleep-Related Breathing DisorderLearning Objectives
Upon completion of this educational activity, participants should be able to:
- Define the multidimensional nature of healthy sleep
- Analyze the mechanisms and functions of basic sleep processes
- Assess the structure and functions of sleep architecture
- Evaluate sleep disorders using standardized diagnostic criteria
- Conduct comprehensive sleep histories and physical examinations
- Use diagnostic tools for evaluating sleep disorders
- Assess public health and sleep medicine
- Advance research and training programs in sleep medicine
- Evaluate changes in sleep health across the lifespan
- Evaluate sleep health metrics and their relevance to sleep quality
This course is supported by an educational grant from Philips.
Registration Rates
Registration is free for World Sleep Society members and nonmembers.
All registrations will need a free online account with World Sleep Society to register.
Create your World Sleep Society account. For additional assistance visit the help page.
Registration Type Rate Non-Member $0 Regular Member $0 Student Member $0 Allied-Health/Technician Member $0 Membership questions? Email info@worldsleepsociety.org.
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Contains 25 Component(s)
A three-hour self-guided course for non-RLS specialists to feel confident identifying and managing RLS in their patients. The course covers the diagnosis of RLS, the AASM's treatment guidelines, therapeutic options, and RLS presentation in special populations. Log into your World Sleep Society account to view for free!
Overview:
This course was designed to help non-specialist healthcare providers feel confident identifying and managing RLS in their patients. The course covers the diagnosis of RLS, the AASM's treatment guidelines, and RLS in two special populations: children and pregnant women.
This course is split into 10 brief units, each containing a 10-15 minute video lecture, a 5-10 minute video highlighting RLS cases related to the topic, and a quiz. You may move through the units at your own speed and in whatever order you choose.
Course Contents:
- Unit 1: General Introduction to RLS
- Unit 2: Overview of the AASM Treatment Guidelines
- Unit 3: Alpha-2-Delta Ligands
- Unit 4: Iron Treatments
- Unit 5: Opioids
- Unit 6: Dopamine Agonists and Augmentation
- Unit 7: Biological Basis of Augmentation
- Unit 8: RLS and Pregnancy
- Unit 9: RLS in Children
- Unit 10: Neurostimulation
Course Chairs
- Christopher Earley, MBBCh, PhD
- Maria Paola Mogavero, MD, PhD
- Gulcin Benbir Senel, MD
Learning Objectives:
Upon completion of this course, participants will be able to:
- Distinguish Restless Legs Syndrome from mimics in patients within a primary care setting
- Classify different treatment options based on the strength of the recommendation in the AASM Treatment Guidelines
- Describe augmentation and its biological basis as well as diagnose augmentation in patients with RLS
- Diagnose RLS in two special populations: Children and pregnant women
This course is a joint session between the World Sleep Society (WSS) and the International Restless Legs Syndrome Study Group (IRLSSG)
This course is supported by an educational grant from Noctrix Health.
Christopher J. Earley, MBBCh, PhD
Course Co-Chair
Christopher Earley, MBBCh, PhD completed his medical degree as well as a PhD in Pharmacology from the University College in Galway, Ireland. He went on to complete a residency in Internal Medicine at Baylor Medical College and a residency in Neurology at the University of Charlottesville in Virginia. Dr. Earley has been a faculty member at John Hopkins since 1991. Currently he is a professor of Neurology at Johns Hopkins School of Medicine, where he is also the co-director of the Johns Hopkins Center for Restless Legs. His research and clinical interests are devoted to Sleep Medicine with special interest in Restless Legs Syndrome. Dr. Earley also serves as the Chair of the RLS Foundation Scientific and Medical Advisory Board.
Maria Paola Mogavero, MD, PhD
Course Co-Chair
Dr. Maria Paola Mogavero is a board-certified Neurologist and Sleep Medicine specialist with a robust background in clinical care and sleep research. She currently serves as a Neurology Researcher at the Sleep Medicine Centre of the “Vita-Salute” San Raffaele University, IRCCS San Raffaele Hospital in Milan, Italy, where she is also pursuing her PhD. Dr. Mogavero earned a Level II Master’s Degree in Sleep Medicine from the Alma Mater Studiorum – University of Bologna.
She holds several academic teaching roles, including the Level II Master in Sleep Medicine at the University of Bologna, the Level II Master in Clinical Sleep Medicine at the University of Foggia, and the Catania High School – University of Catania. She also serves on the Didactic Committee of the Annual Residential Course in Sleep Medicine of the Italian Academy of Sleep Medicine, the most established Italian training program in the field.
Within the International Restless Legs Syndrome Study Group (IRLSSG), Dr. Mogavero co-chairs, alongside Dr. Elias Karroum, a dedicated task force focused on adult RLS phenotyping. She is also an active member of the IRLSSG Website Task Force.
Dr. Mogavero has authored over 85 peer-reviewed publications and contributed to various book chapters. She is a frequent speaker at national and international conferences, including the World Sleep Congress, APSS, ESRS and Italian Academy of Sleep Medicine (AIMS) congresses, where she has presented on topics such as sleep related movement disorders. Her primary research interests focus on Neurology and Sleep Disorders, with a special emphasis on sleep-related movement disorders in both pediatric and adult populations. Her significant contributions to sleep research have been recognized with multiple prestigious awards, including the Wayne Hening Young Investigator Award from the International Restless Legs Syndrome Study Group (2022 and 2023) and the New Investigator Award from the World Sleep Society (2023)
Gulcin Benbir Senel, MD
Course Co-Chair
Gulcin Benbir Senel, MD, is Professor of Neurology at Istanbul University-Cerrahpasa. Her research is concentrated in the field of sleep medicine, with particular expertise in restless legs syndrome (RLS), REM sleep behavior disorder, and narcolepsy.
Professor Benbir Senel earned her medical degree from Marmara University English Faculty of Medicine in Istanbul, Turkey, in 2002. She completed her postdoctoral training and residency in Neurology at Istanbul University, Cerrahpasa Faculty of Medicine, Department of Neurology in 2008. She advanced to the rank of Professor of Neurology at Istanbul University-Cerrahpasa in August 2022.
Professor Benbir Senel has a broad background in Neurology, with specific training and expertise in Sleep Medicine. She has served as principal investigator (PI) or co-investigator on numerous university- and TUBITAK-funded grants, where she has been responsible for developing effective measures of sleep quality and sleep disorders relevant to patients with neurological disorders. Her work has also involved establishing strong ties with community providers to facilitate the recruitment and long-term tracking of research participants. She has demonstrated her ability to administer research projects effectively, including staffing, research protections, and budget management, and has a strong record of peer-reviewed publications.
Professor Benbir Senel’s early publications addressed neurological diseases in addition to sleep disorders in adults. Her clinical work and research studies focus on sleep medicine, and her publications document emerging concerns regarding the consequences of sleep-related disorders. She has also worked to guide primary care providers in recognizing symptoms, assessing sleep and its disorders, and applying appropriate interventions. She is the author of many Turkish book chapters and edited the main textbook of “Sleep” in Turkish literature.
Professor Benbir Senel’s research has also contributed to the understanding of restless sleep disorder, a newly defined disorder, in both children and adults. Her work has explored its association with other sleep disorders and medical conditions.
Professor Benbir Senel is a board member of the International Restless Legs Syndrome Study Group. She is also actively involved in several other professional organizations, including serving as Editor of the Journal of Turkish Sleep Medicine, Executive Member of the Turkish Sleep Medicine Society, Founder President of the Turkish Narcolepsy Network, Member of the International REM Sleep Behavior Disorder Study Group, and Teaching Committee member of the European Narcolepsy Network.
Diego Garcia-Borreguero, MD, PhD
Course Faculty
Diego García-Borreguero is the Director of the Sleep Research Institute in Madrid, Spain. Until 2005, he was Director of the Sleep Disorders Center at the Department of Neurology of the Fundación Jiménez Díaz (Autonomous University of Madrid). He has completed fellowships in sleep medicine and sleep research at the National Institutes of Health in Bethesda, Maryland, USA and underwent residency training at the Max Planck Institute in Munich, Germany. He received his MD from the University of Navarre (Pamplona, Spain) and completed his PhD at the University of Munich.
García-Borreguero’s main area of research is movement disorders in sleep, and restless legs syndrome (RLS) in particular. He has published extensively in this field in international peer-reviewed journals. He is also a member of numerous professional organizations related to the field of sleep science, such as the World Association of Sleep Medicine (WASM) and the American Academy of Sleep Medicine (elected fellow).
Ravi Gupta, MD, PhD
Course Faculty
Elias Karroum, MD, PhD
Course Faculty
Elias Karroum, MD, PhD, is a neurologist who treats and researches movement-related sleep disorders, including restless legs syndrome (RLS), periodic limb movements, and sleep disorders in neurological conditions.
Dr. Karroum attended medical school at Saint-Joseph University in Beirut, Lebanon, and earned a PhD in neuroscience from Pierre and Marie Curie University in Paris.
He completed a neurological residency at Southern Illinois University, a sleep medicine fellowship at Emory University in Atlanta, and a clinical neurophysiology fellowship at Vanderbilt University in Nashville.
Previously, he was the associate program director for the sleep medicine fellowship at The George Washington University School of Medicine in Washington, DC.
Karem Parejo, MD
Course Faculty
Karem Parejo, MD graduated as a surgeon from the Universidad del Rosario (UR) and, later, specialized in Neurology at the Pontifical Universidad Javeriana (PUJ). She completed her fellowship in Sleep Medicine at Stanford University. Dr. Parejo's areas of expertise include Insomnia, Narcolepsy, Dementia, Sleep Apnea, Parasomnias, Parkinson's Disease and Restless Legs. Dr. Parejo is also the President of the Colombian Association of Sueño Medicine.
Denise Sharon, MD, PhD
Course Faculty
Denise Sharon, MD, PhD, a Fellow of the American Academy of Sleep Medicine is Board Certified in Sleep Medicine by the ABSM, providing sleep medicine care and teaching fellows, residents and students. She specializes in treating a wide range of sleep and sleep related movement disorders, including sleep related breathing disorders, excessive sleepiness, insomnia, restless legs syndrome (RLS), periodic limb movement disorder (PLMD), parasomnias and sleep disorders associated with trauma and other medical conditions. Her research interests center on RLS, PLMD and quality of care in sleep medicine.
Dr. Sharon’s clinical work with adolescents, college students and shift workers further inspired her interest in sleep-wake cycle disorders. Her research has focused on the brain’s impact on sleep patterns in children, adults and the elderly. In addition, her findings on RLS have been featured in multiple peer-reviewed journals, and she has been a presenter at conferences across the United States and internationally.
Dr. Sharon worked with the American Academy of Sleep Medicine on several projects, including most recently, the development of RLS and PLMD treatment guidelines for children and adults. She is also part of the International RLS Study Group and the RLS Foundation’s Scientific and Medical Advisory Board. Throughout her career she worked to promote sleep medicine and combined her clinical and research work with actively engaging in association work. An advocate of education, she serves as a clinical assistant professor of medicine at the Keck School of Medicine of USC.
Dr. Sharon was born in Romania, was raised in Israel, studied in Italy and completed her medical studies and a psychiatry residency in Israel. She received her PhD in clinical psychology at Temple University in Philadelphia, became interested in neurophysiology and was among the first providers to become Board Certified in Sleep Medicine. For over 25 years she is trying to inspire a new generation of sleep medicine providers. Outside of work, she enjoys entertaining friends and family, reading, attending operas and visiting museums.
Rosalia Silvestri, MD
Course Faculty
Professor Rosalia Silvestri is as Associate Professor of Neurology at the Department of Clinical and Experimental Medicine of the “G. Martino” University Hospital in Messina. In addition to her academic role, she is the Medical Director of the Regional Center for the Diagnosis and Treatment of Sleep Disorders, which operates within the Neurophysiopathology and Movement Disorders Unit at the same institution.
Her primary research interests and clinical expertise include sleep-related movement disorders, particularly Restless Legs Syndrome (RLS), gender differences in sleep pathologies, epilepsy, parasomnias, and the interplay between sleep dysfunction and neurological disorders.
Professor Silvestri served as President of the European Restless Legs Syndrome Study Group (EURLS-SG) from 2019 to 2023. Currently, she is a board member of the International Restless Legs Syndrome Study Group (IRLSSG).Ambra Stefani, MD, PhD
Course Faculty
Ambra Stefani is senior neurologist and neuroscientist working at the Medical University Innsbruck, Austria. Her main research interests are restless legs syndrome (clinical, laboratory, and imaging-based characterization, and pathogenetic mechanisms), isolated RBD (clinical, video-polysomnographic and biomarker characterization), and the link between sleep and neurodegeneration. I have a broad background in neurology and sleep neurophysiology, with specific training expertise in sleep medicine and 12-year research experience in sleep science.
John Winkelman, MD, PhD
Course Faculty
Dr. Winkelman received his PhD in Psychobiology from Harvard University, an MD from Harvard Medical School and completed both a residency in Psychiatry and a fellowship in Sleep Medicine at Massachusetts General Hospital.
He is a Professor of Psychiatry at Harvard Medical School and Chief of the Sleep Disorders Clinical Research Program in the Department of Psychiatry at Massachusetts General Hospital.
Dr. Winkelman’s research has primarily focused in two areas: 1) epidemiology, physiology, cardiovascular consequences and treatment of restless legs syndrome, and 2) neurobiology and treatment of insomnia. He has lectured in and directed post-graduate medical education courses in sleep disorders nationally and internationally. He has chaired practice guidelines for RLS for the American Academy of Neurology and the American Academy of Sleep Medicine and is currently the Chairman of the International Restless Legs Syndrome Study Group. He has published more than 200 articles, reviews and book chapters.
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Contains 18 Component(s)
Monthly Webinars on sleep-related topics which are selected based on their relevance to the clinical practice of sleep medicine in Africa. Webinars are one hour in length.
Sleep-related topics are selected based on relevance to clinical practice of sleep medicine in Africa. Webinars are beneficial to both residents in-training and consultants in the areas of Neurology, Psychiatry, Pediatrics, Ear Nose Throat, Ophthalmology, Dentistry, Anesthesiology, and Family Medicine. Students, under the platform of the Nigerian Sleep Society, and other health personnel such as nurses, and physiotherapists are also encouraged to attend.
The Webinars last for an hour and questions are discussed at the end. The Webinars have been well received by all the participants across Africa and beyond.
-
Register
- Non-member - Free!
- Regular Member - Free!
- More Information
-
Register
-
Contains 20 Component(s)
Gathering of leaders or appointed representatives of each affiliate society member. Discussions are centered on the three areas of focus: Education, Research, and Advocacy.
Affiliate Societies are professional sleep societies that are official members of World Sleep Society. There are over 50 Affiliate Societies across Africa, Asia, Europe, Oceania, and the Americas. See all the current members here: worldsleepsociety.org/affiliate-societies/list/
World Sleep Society convenes these sleep societies regularly through Assemblies to strengthen collaboration, share knowledge, and amplify impact across regions.
The Assembly provides a forum for:
- Facilitating person-to-person connections among sleep societies worldwide
- Sharing regional initiatives, challenges, and successes
- Strengthening collaboration across countries and disciplines
- Identifying opportunities for alignment and collective action among sleep societies
Any professional sleep society that has interest in joining World Sleep Society as an Affiliate Society can learn more about the benefits, criteria, and application here: worldsleepsociety.org/affiliate-societies/
March 2026 Assembly: Sleep Health Advocacy
The March 2026 Assembly focused on how Affiliate Societies are advancing sleep health through advocacy initiatives at local, national, and regional levels.
Discussions highlighted:
- Public safety campaigns addressing drowsy driving
- Workplace and hospitality initiatives promoting sleep-friendly environments
- Policy engagement efforts influencing national decision-making
- Strategies for increasing public awareness and education
Affiliate Societies shared practical examples of how advocacy efforts can lead to measurable improvements in health, safety, and quality of life.
- Registration Closed. Maximum Number of Registrants reached.
- More Information
-
Contains 9 Component(s)
Selection of World Sleep 2025 presentations with a focus on Psychiatry. Log into your World Sleep Society account to view for free!
Overview
This curated Learning Center Series from World Sleep Society collects over 17 hours of presentations exploring the relationship between sleep health, sleep disorders, and mental health across the lifespan. The presentations were recorded during World Sleep 2025 in Singapore and include two full courses, a keynote address, and a track of research symposia. Additional focus is dedicated to consumer health trackers as more patients integrate these devices into their daily life.
Find summaries, presentations, and speakers for each session in the Series Outline tab. Watch the sessions in the Presentations tab.
Audience
The series is intended for psychiatrists and sleep medicine practitioners, bridging the psychiatry and sleep medicine specialties. Those who are newer to sleep medicine are encouraged to begin with the Sleep, psychiatry and mental health course. Those interested in the latest research at the intersection of psychiatry and sleep can begin with the symposium sessions.
Included topics
• Sleep and psychiatric disorders
• Sleep loss and cognitive and emotional impact
• Adolescent sleep and mental health
• Advances in behavioral and psychological treatment for insomnia
• Sleep disturbances across mental health conditions
• Wake and sleep regulation in psychiatric disorders
Access is provided by the Learning Center as part of World Sleep Society’s commitment to advancing global sleep health education.
Registration Rates
Registration is free for World Sleep Society members and nonmembers.
All registrations will need a free online account with World Sleep Society to register.
Create your World Sleep Society account. For additional assistance visit the help page.
Registration Type Rate Non-Member $0 Regular Member $0 Student Member $0 Allied-Health/Technician Member $0 Membership questions? Email info@worldsleepsociety.org.
Sleep and Mental Health Series Outline
Over 17 hours of content in sleep and mental health is available in the series. Find the outline of presentations below, including summaries, speakers, and presentation titles.
Course: Sleep, psychiatry and mental health
Chairs: Ahmed BaHammam (Saudi Arabia), Charles Morin (Canada) • Duration: 218 Minutes
This course discusses how sleep plays a role in emotional regulation and the reciprocal relationship between sleep disturbances and mental health. The course will focus on different psychiatric disorders and their relationship with sleep.
Presentations
- Epidemiology of sleep and psychiatric disorders: Charles Morin (Canada)
- The bi-directional relationships between insomnia and major depression: Clinical and diagnostic: Christoph Nissen (Switzerland)
- Sleep and post-traumatic stress disorders: Laura Palagini (Italy)
- Neuropsychiatric manifestations in narcolepsy: Ahmed BaHammam (Saudi Arabia)
- Pharmacological and behavioral management of sleep disturbances in psychiatric disorders: Christoph Nissen (Switzerland)
Course: Wearables and sleep trackers
Chairs: Michael Chee (Singapore), Cathy Goldstein (United States) • Duration: 226 Minutes
Persons worldwide track sleep with ubiquitous fitness trackers and smart watches. A large body of research now demonstrates that consumer geared health tracking devices have comparable sleep estimation capabilities to FDA cleared actigraphy. This course provides practical guidance on device selection and use.
Presentations
- Introduction: Michael Chee (Singapore)
- Multi-sensor wearable health trackers: Measurements and outputs: Mathias Baumert (Australia)
- Interpreting performance evaluation studies: Choosing the right device for your needs: Ju Lynn Ong (Singapore)
- Sleep tracker use in healthy individuals: Kelly Baron (United States)
Keynote: Sleep and development: Exploring the impact of sleep on mental health in children
Speaker: Tiina Paunio (Finland) • Duration: 44 Minutes
The presentation examined how infant sleep and brain development are closely connected. Using Finnish longitudinal studies, researchers found that sleep patterns stabilize during the first two years, while sleep problems in infancy were linked to emotional, behavioral, and attention difficulties later in childhood.
Presentations
- Introduction: Markku Partinen (Finland)
- Sleep and development: Exploring the impact of sleep on mental health in children: Tiina Paunio (Finland)
Symposium: Sleep loss increases intrusive memories: But how?
Chairs: Sean Drummond (Australia), Jessica Ogden (Australia) • Duration: 89 Minutes
The symposium explores how sleep influences intrusive memories, a key symptom of PTSD. Research suggests sleep disturbances contribute to PTSD, but the underlying mechanisms remain unclear. Presentations will examine factors such as disrupted sleep, emotion regulation, memory consolidation, and executive control using diverse experimental approaches and clinical populations. The symposium features recent findings from an international, multidisciplinary group of researchers.
Presentations
- The impact of time of day and sleep architecture on the frequency and intensity of intrusions following an analogue trauma exposure: Jessica Paterson (Australia)
- Cognitive consequences of local sleep: From mental fatigue to hypersomnia's: Arthur LeCoz (France)
- Day-to-day relationships between sleep and intrusive memories following experimental trauma exposure: Jessica Ogden (Australia)
- The effects of sleep restriction and insomnia disorder on intrusive memories for emotional scenes: Tony Cunningham (United States)
Symposium: Adolescent sleep and mental health: From challenges to solutions
Chairs: Shirley Xin Li (Hong Kong), Michael Gradisar (Sweden) • Duration: 92 Minutes
This symposium examines how poor sleep affects adolescent mental health, cognition, and school performance. Researchers from Taiwan, Norway, China, and Hong Kong will present findings on sleep quality, insomnia subtypes, anxiety, and interventions such as motivational interviewing and cognitive behavioral therapy. The session aims to highlight both the challenges adolescents face and practical strategies to improve sleep and well-being.
Presentations
- Caught between books and beds: The impact of sleep deprivation and sleep disturbance on Taiwanese adolescents' mental health: Ya-wen Jan (Taiwan)
- Adolescent sleep and implications for school performance and mental health - Results from a Norwegian cohort of older adolescents: Ingvild West Saxvig (Norway)
- New subtypes of insomnia and their association with mental health in children and adolescents: Guanghai Wang (China)
- Late owl phenomenon and sleep deprivation in adolescents: is advancing bedtime effective: Sijing Chen (Hong Kong)
- Comorbid insomnia and anxiety in youth- Shall we tackle sleep or anxiety problem in treatment: Xiao Li (Hong Kong)
Symposium: Consumer sleep technology - Usefulness and reliability for patients and practitioners
Chair: Walter McNicholas (Ireland) • Duration: 91 Minutes
This symposium explores the growing use of consumer sleep technologies (CSTs), such as wearables and sleep apps, in monitoring and managing sleep problems. While CSTs offer accessible alternatives to traditional sleep medicine, concerns remain about their accuracy, validation, and commercial bias. Experts from multiple countries will discuss the benefits, risks, patient perspectives, new innovations, and challenges of integrating CSTs into sleep care.
Presentations
- Overviewing the current use of consumer sleep technologies by both the patients and healthcare professionals: Walter McNicholas (Ireland)
- How patients perceive and use consumer sleep technology: Michael Grandner (United States)
- Innovations on consumer sleep technology for sleep tracking and scoring: Erna Sif Arnardottir (Iceland)
- Innovations on consumer sleep technology for the sleep-disordered breathing: Timo Leppanen (Finland)
- Sponsorship bias and lack of validation- Exploring the negative effects of commercial aspects on the validation of consumer sleep technologies: Gabriel Natan Pires (Brazil)
Symposium: Novel developments in psychotherapy for insomnia
Chairs: Elisabeth Hertenstein (Switzerland), Kai Spiegelhalder (Germany) • Duration:93 Minutes
This symposium focuses on improving treatment for chronic insomnia beyond standard CBT-I. Researchers will present innovations such as app-based CBT-I with wearable feedback, Acceptance and Commitment Therapy (ACT-I) for patients who do not respond to CBT-I, brief bedtime-restriction therapy, and internet-based stepped-care approaches to expand access and improve effectiveness of insomnia treatment.
Presentations
- NEW SLEEP: using accurate and daily sleep feedback in home environments in order to improve sleep: Manuel Schabus (Austria)
- Acceptance and commitment therapy versus cognitive behavioral therapy for insomnia: Outcomes from a RCT and predictors of treatment response: Renatha El-Rafihi Ferreira (Brazil)
- Addressing non-response and improving implementation as primary challenges for the future oh psychotherapy for insomnia: Elisabeth Hertenstein (Switzerland)
- Implementing CBT-I in routine clinical care using a stepped care model: A randomized controlled trial: Kai Spiegelhalder (Germany)
Symposium: Targeting sleep disturbances in mental disorders: Does it make the difference?
Chair: Pierre Alexis Geoffroy (France) • Duration: 97 Minutes
This symposium examines how sleep disturbances contribute to mental health disorders by affecting brain plasticity and stress regulation. Experts will discuss sleep and circadian disruptions in psychosis, the role of nightmares, insomnia treatments including orexin-targeting medications, and whether improving sleep can reduce suicide risk. The session highlights emerging approaches linking sleep treatment with better mental health outcomes.
Presentations
- Sleep and circadian rhythm disturbance in psychosis, does targeting sleep and circadian function improve outcomes: Nicholas Meyer (United Kingdom)
- A "wake up call" for nightmares in adults: Management and implications for mental health: Pierre Alexis Geoffroy (France)
- Treating insomnia comorbid with mood and anxiety disorders: Data on CBT-I and pharmacological treatments: Laura Palagini (Italy)
- Reducing suicidality through insomnia treatment is it possible: Vaughn McCall (United States)
Oral Abstract: Psychiatric disorders affecting wake/sleep
Chairs: Joey Chan (Hong Kong), K Mathu Prathibha (India) • Duration: 74 Minutes
Summary
This session explores the relationship between sleep and mental health across a range of conditions and treatments. Topics include the impact of insomnia, sleep disturbances in young adults and schizophrenia, sleep problems during morphine withdrawal, and the role of sleep in PTSD severity. It also examines emerging treatment approaches, including orexin antagonists and EEG markers predicting ketamine treatment response.Presentations:
- Impact of insomnia symptoms on the clinical outcomes among patients with major depressive disorder and eveningness- results from a randomized controlled trial: Joey Chan (Hong Kong)
- Sleep and mental disorders in young adults: A national prospective diagnostic study: Borge Sivertsen (Norway)
- A PVTD2R-CeA circuit underlies sleep disturbance and negative effects induced by morphine withdrawal: Wenjun Chen (China)
- Effects of a dual orexin-receptor antagonist on sleep architecture and opioid withdrawal severity during buprenorphine taper: Andrew Huhn (United States)
- Sleep profiles in schizophrenia inpatients :A cross-sectional study of clinical and genetic associations: Kseniia Gasenko (Russian Federation)
- Pre-infusion EEG vigilance dynamics as predictive indicators of ketamine response in major depression: A placebo-controlled study: Martin Brunovsky (Czech Republic)
- Sleep and PTSD symptom severity in military personnel: Insights from multi-night ecological recordings: Emeric Saguin (France)
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Contains 25 Component(s)
Full library of recordings from the Asian Society of Sleep Medicine 2025 meeting in Singapore.
ASSM 2025 Meeting: Advancing Sleep Health in Asia
The Asian Society of Sleep Medicine (ASSM) 2025 Scientific Meeting was held as an integral component of World Sleep 2025, the 18th World Sleep Congress, in Singapore on September 6-7, 2025. As the official host society for World Sleep 2025, ASSM organized a comprehensive two-day program featuring keynote presentations, symposia, oral and poster abstract presentations, and specialized workshops focused on advancing sleep medicine and research across Asia.
The ASSM meeting program complemented the main World Sleep Congress (September 8-10, 2025) by providing focused sessions on regional sleep health challenges and fostering international exchange and knowledge transfer specific to Asian populations. This collaboration between ASSM and the World Sleep Society represents a unified effort to promote sleep health awareness and advance clinical practice globally while addressing the unique needs of the Asian sleep medicine community.
Organizing Committee
Yuichi Inoue (Japan) – Chair Naricha Chirakalwasan (Thailand) Ahmed S. BaHammam (Saudi Arabia) SC Hong (Korea) Fang Han (China) Stijn Massar (Singapore) Hiroshi Kadotani (Japan) Toh Song Tar (Singapore) KiYoung Jung (Korea) Yukiyoshi Sumi (Japan) Leow Leong-Chai (Singapore) Yun Kwok Wing (Hong Kong) Michael Chee (Singapore) Yuta Takano (Japan) Program Committee
Ahmed S. BaHammam (Saudi Arabia) Seockhoon Chung (Korea) Duong-Quy Sy (Vietnam) Seung Bong Hong (Korea) Fang Han (China) Seung-Chul Hong (Korea) Hiroshi Kadotani (Japan) Stijn Massar (Singapore) JC Suri (India) Tayard Desudchit (Thailand) Leow Leong-Chai (Singapore) Toh Song Tar (Singapore) Michael Chee (Singapore) Yuichi Inoue (Japan) Mohamed A. Al-Abri (Oman) Yuta Takano (Japan) Naricha Chirakalwasan (Thailand) Yun-Kwok Wing (Hong Kong) Ning-Hung Chen (Taiwan) Zhi-Li Huang (China) Abstracts
The ASSM 2025 meeting featured presentations covering multiple oral and poster abstract sessions across diverse topics in sleep medicine, including:
- Sleep-disordered breathing and obstructive sleep apnea
- Narcolepsy and hypersomnolence disorders
- Insomnia and sleep health
- Pediatric sleep medicine
- Circadian rhythm disorders
- Sleep and neurodegenerative diseases
- Dental sleep medicine and bruxism
- Sleep technology and AI applications
-
Register
- Non-member - $120
- Regular Member - $80
- Student Member - $80
- Technician Member - $80
- More Information
-
Contains 2 Component(s)
This symposium was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the course by navigating to the timestamp indicated below.
0:00:00
Introduction: The phenotypic clinical diversity of RLS
Diego Garcia-Borreguero (Spain)
0:32:20
Pediatric RLS phenotypes: Early onset and unique challenges
Gulcin Benbir Senel (Turkey)
1:00:05
Adult RLS phenotypes: Clinical variability in adulthood
Claudia Trenkwalder (Germany)
Genetic insights into RLS: Shared variants and comorbidities
Arthur Walters (United States)Summary
Restless Legs Syndrome (RLS) encompasses a diverse spectrum of clinical presentations, each with unique implications for diagnosis, management, and research. This symposium will explore the proposed distinct phenotypes of RLS, highlighting shared genetic underpinnings, clinical manifestations, and treatment challenges. Experts in the field will discuss the current understanding of these phenotypes and identify areas for future research and therapeutic advancements.
The first presentation will provide a comprehensive overview of these diverse clinical profiles, setting the stage for deeper exploration in subsequent talks. It will highlight the variability in symptom frequency and severity, drawing on findings from recent clinical studies and patient-reported outcomes. Attendees will gain a foundational understanding of the phenotypic spectrum of RLS symptoms, equipping them with the knowledge to contextualize more specific discussions on subtypes, comorbidities, and management strategies. Also, the rationale for selection of different therapies across phenotypes will be outlined and discussed.
The second presentation will provide a detailed review of pediatric RLS phenotypes, drawing from contemporary literature to explore how RLS presents differently in children compared to adults. The talk will highlight the often subtle and atypical symptoms in children, including behavioral manifestations such as restlessness, inattention, or sleep resistance, which can mimic conditions like ADHD. The role of iron deficiency, developmental changes, and familial predisposition as key factors influencing pediatric RLS will be presented . Additionally, the overlap between RLS and other pediatric sleep disorders will be discussed, such as periodic limb movement disorder (PLMD), and the importance of early diagnosis to prevent long-term consequences on sleep and neurocognitive development.
The third speaker will provide a comprehensive review of adult RLS phenotypes, drawing from the latest literature to explore the variability in clinical presentations, relationship with insomnia, cardiovascular disorders, and mood disorders, among other comorbidities that contribute to symptom severity and progression. This talk with present the findings from adult RLS literature and discuss the implications for personalized diagnostic and therapeutic approaches in clinical practice.
Finally, the symposium will explore the genetic underpinnings of these associations, presenting findings from two innovative studies leveraging Genome-Wide Association Studies (GWAS) and Phenome-Wide Association Studies (PheWAS). The first study identifies 365 genetic variants associated with RLS, including significant overlap with hypertension, insomnia, ADHD, and circadian rhythm disturbances, providing insights into shared genetic susceptibilities. The second study extends these findings by replicating RLS associations for 84 variants and identifying additional links with conditions like thyroid disease, rheumatoid arthritis, and diabetes. Together, these studies demonstrate the utility of GWAS and PheWAS approaches in unraveling the genetic architecture of RLS and its frequent co-occurrence with other medical conditions. Attendees will gain a deeper understanding of how shared genetic pathways may inform future diagnostic and therapeutic strategies for RLS and its comorbidities.Learning Objectives:
Upon completion of this CME activity, participants will be able to:
• Gain an understanding of the phenotypic spectrum of RLS symptoms, equipping them with the knowledge to contextualize more specific discussions on subtypes, comorbidities, and management
• Recognize that RLS manifests with unique presentations in pediatric populations. It will highlight the often subtle and atypical symptoms in children, including behavioral manifestations such as restlessness, inattention, or sleep resistance, which can mimic conditions like ADHD. It will emphasize the role of iron deficiency, developmental changes, and familial predisposition
• Demonstrate that RLS exhibits diverse phenotypes in adulthood, as influenced by age, gender, and environmental factors. The talk will provide a comprehensive review of RLS phenotypes, drawing from the latest literature to explore the variability in clinical presentations, relationship with insomnia, cardiovascular and mood disorders, and contribute to symptom severity and progression
• Describe findings from two studies on GWAS and PheWAS. While the first study identified 365 genetic variants associated with RLS, including significant overlap with hypertension, insomnia, ADHD, and circadian disturbances, the second replicated associations for 84 variants and identified additional links with thyroid disease, rheumatoid arthritis, and diabetes-
Register
- Non-member - $100
- Regular Member - $100
- Student Member - $100
- Technician Member - $100
- More Information
-
Register
-
Contains 165 Product(s)
Access the full library of scientific program recordings from World Sleep 2025 in Singapore. (Courses Sold Separately)
After purchasing the bundle, navigate to the Content tab and activate sessions of interest to add them to your dashboard.
This bundle gives you access to the following sessions:
Keynotes
- K-01: Thomas Penzel: Innovations in sleep technology: Advancing diagnosis and treatment of sleep disorders
- K-02: Russell Foster: Light, circadian rhythms and sleep: Fundamental mechanisms to new therapeutics
- K-03: Tiina Paunio: Sleep and development: Exploring the impact of sleep on mental health in children
- K-04: Hiroki R. Ueda: Towards human systems biology of sleep/wake cycles: The role of calcium and phosphorylation in sleep
- K-05: Lauren Hale: Sleep health as a human right
- K-06: Bei Bei: Behavioral sleep interventions in women across the lifespan
- K-07: Mary Ip: Cardiometabolic consequences of obstructive sleep apnea: Are we making progress?
- K-08: Célyne Bastien: Sleep misperception: A waking perspective
- K-09: Takafumi Kato: Advances in dental sleep medicine: Understanding the pathophysiology of sleep bruxism and co-existing sleep disorders
- K-10: Ronald Postuma: REM sleep behavior disorder: Gateway to early diagnosis and therapy in synucleinopathies
- K-11: Björn Rasch: Sleep and memory: Current state of research and future needs
- K-12: Joshua J. Gooley: The hard facts supporting later learning start times
Symposia
- S-01: Pharmacotherapy of obstructive sleep apnea in 2025
- S-02: The Global Adolescent Sleep Project (GASP): A Summary of the Findings, Research Gaps and Future Directions
- S-03: Challenges of using cognitive behavioral treatment for insomnia in specific patient groups and settings
- S-04: WSS Task Force recommendations for use of consumer health trackers for sleep tracking
- S-05: OSA, neurodegeneration and neurocognitive decline: New insights and future directions
- S-06: Sleep health and aging: A decade research and its global implications
- S-07: Hypersomnolence in focus: Orexin as the key to treating comorbidities and secondary diseases?
- S-08: Decoding neurological sleep disorders: Genetic and omics approaches to advance clinical practice
- S-09: The medical and dental aspects of Asian and Caucasian populations in cardiosleep outcomes with oral appliance therapy on sleep-disordered breathing, blood pressure control, and maladaptive myocardial remodelling
- S-10: Mechanisms underlying REM sleep memory modification
- S-11: Prefrontal cortical orchestration of sleep: The missing link between sleep disruption and psychiatric disease?
- S-12: Narcolepsy: Examining the science, impact, and current unmet needs
- S-13: World Health Organization report on road safety: Pathway to global professional driver work hours regulations
- S-14: 45 years on from CPAP: Therapeutic options for pediatric OSA
- S-15: Sleep loss increases intrusive memories: But, how?
- S-16: Sleep and health problems among shift workers across the world: Novel findings, challenges, and future perspectives
- S-17: Discussion group: Leading the charge: Sleep medicine’s role in a healthier planet
- S-18: iRBD biomarkers through the lens of young scientists: What do we have and what do we need?
- S-19: Associations of accelerometry-derived sleep variables with age-related disease outcomes and variations across sociodemographic groups and wearing time: Findings from the CHARGE Accelerometry Working Group
- S-20: Exploring the intersections of sleep bruxism, orofacial pain, insomnia, and obstructive sleep apnea
- S-21: Current evidence on cardiometabolic diseases and sleep disorders; Asian Perspectives
- S-22: Patterns of plates and pillows: Exploring the bidirectional interplay between sleep and circadian rhythms, and eating behavior and metabolic outcomes
- S-23: Harnessing sensors and big data to decipher the link between sleep health and cardiovascular risk: Innovations and applications
- S-24: Novel approaches to address sleep problems in young children: Evidence from 5 randomized controlled trials
- S-25: Open data and open science in sleep medicine and sleep research
- S-26: Advancing biomarkers in isolated REM sleep behavior disorder: Pathways to clinical implementation
- S-27: Symptom subtypes of obstructive sleep apnea: Past, present, and future
- S-28: Global insights and emerging perspectives on sleep (ir)regularity
- S-29: ISSS symposium: Neurostimulation in the treatment obstructive sleep apnea: Current understanding, challenges and the future
- S-30: New insights and opportunities into sleep and pregnancy health with wearable big data and digital health interventions
- S-31: Sleep and digital media myth-busting: What should the recommended guidelines be for children, adolescents and young adults?
- S-32: Sleep, sleep disorders and neurodegenerative diseases: Novel insights on mechanisms and interventions
S-33: Global sleep health in turbulent times: Effects of political instability on funding, advocacy and health services(Session Not Available)- S-34: Discussion group: Artificial intelligence in sleep medicine: The good, the bad, the ugly
- S-35: Sleep-Immune interactions and the role of sleep in Long COVID
- S-36: Discussion group: Cannabis for the treatment of sleep disorders: What's the POT-ential?
- S-37: Social and neuropsychological outcomes in central disorders of hypersomnolence
- S-38: New circuits underlying REM sleep regulation and homoeostasis
- S-39: Sleep well, feel well: Enhancing mental health across the lifespan through sleep interventions
- S-40: Best of SLEEP MEDICINE – Journal Highlights 2025
- S-41: To wake up or continue sleep: Arousal dynamics and sleep stability in health and disease
- S-42: Revolutionizing personalized medicine in OSA: Exploring new treatment modalities
- S-43: Insomnia Sub-typing: Pathophysiology, phenotypes and differential treatment response
- S-44: Sleep and cardiometabolic health: Pathophysiology, and novel preventive and therapeutic strategies
- S-45: The role of autovideosomnography in research: How AI and big data are transforming pediatric sleep and development research
- S-46: How sleep shapes memory dynamics from the lens of reactivation: New insights and future directions
- S-47: Beyond the lab: Measuring sleep and circadian rhythms in naturalistic settings
- S-48: Discussion group: Optimizing opioid therapy for restless legs syndrome /Willis-Ekbom disease: Insights from basic science to clinical practice
- S-49: New insights into the waking, sleeping and dreaming brain
- S-50: Bridging sleep research and practice: Leveraging implementation science to improve sleep equity around the globe
S-51: The latest advances in understanding maternal sleep as a modifiable contributor to safer outcomes for mother and baby(Session Not Available)- S-52: Sleep Challenge 2025 Exhibition: Predicting all-cause mortality using physiological signals from the PSG
- S-53: Illuminating the minds: Impact of light exposure on circadian rhythms and health
- S-54: Advancing the definition and management of childhood obstructive sleep apnea (OSA)
- S-55: Advancing ambulatory sleep monitoring and diagnostics through innovative sensor technologies
- S-56: Obesity and the effects of GLP-1 agonists on OSA
- S-57: Narcolepsy meets immunology: Recent global discoveries in its pathophysiology
- S-58: Discussion group: Religious and spiritual determinants of sleep health
- S-59: Understanding the therapeutic opportunities of iron treatment in RLS
- S-60: Collaborative strategies for optimizing pediatric sleep health
- S-61: Sleep and the microbiome
S-62: Rethinking mask selection for CPAP and non-invasive ventilation: Facts and perspectives(Session Not Available)- S-63: Global efforts to combat drowsy driving: Opportunities and challenges to save more lives
- S-64: Discussion Group: Managing patients with obstructive sleep apnea and obesity with GLP-1 receptor agonists
- S-65: Night shift work and health risks: Internal desynchrony and underlying mechanisms
- S-66: Phenotypic spectrum of restless legs syndrome: Clinical insights and research perspectives
- S-67: Toward understanding dream interpretation: Mechanisms and functions of REM sleep
- S-68: Adolescent sleep and mental health: From challenges to solutions
- S-69: Discussion group: Global perspectives on sleep health advocacy: Insights and experiences across five continents
- S-70: Ecology of sleep strategies: Placing sleep function in a broader context
- S-71: Cracking the code: Deep signal analysis in sleep-disordered breathing
- S-72: Advances in proteomics, glycomics, and transcriptomics of sleep disorders
S-73: Discussion group: "Simple" snoring: Not simple, not hopeless(Session Not Available)- S-74: Harmonizing pediatric sleep: Navigating the complexities and diversities in managing sleep-related breathing disorders across borders
- S-75: Can OSA in adults be prevented by interventions in children?
- S-76: Practical telemonitoring implementation to improve outcomes in home mechanical ventilation globally, across diverse clinical settings and regions
- S-77: Restless legs syndrome and cardio-cerebro-vascular disease: Clinical associations and implications
- S-78: The role of glia in sleep regulation and sleep homeostasis: Implications for cognitive function and mental health
- S-79: Sleep as a window to health: Artificial intelligence-enabled digital sleep biomarkers for disease prediction
- S-80: Cognitive symptoms in narcolepsy and idiopathic hypersomnia: Neurobiology, functional impact, and clinical research
- S-81: Guiding light for metabolic health: Lessons from bench to field studies for therapeutic insights
- S-82: Tales from the edge: What can we learn about sleep from non-WEIRD (Western, Educated, Industrialized, Rich, and Democratic) sleep research?
- S-83: RBD 1985-2025: Novel perspectives
- S-84: Napping and its associations with health and cognition across the life span
- S-85: Consumer sleep technology: Usefulness and reliability for patients and practitioners
- S-86: AI approaches in pediatric sleep: Unraveling developmental sleep issues
- S-87: Innovative approaches to sleep Disorders and craniofacial health: Bridging research and clinical practice
- S-88: Gender disparities in obesity hypoventilation syndrome: From diagnosis and treatment to outcomes
- S-89: Novel developments in psychotherapy for insomnia
- S-90: Restless legs syndrome: Exploring genetic diversity, racial differences, and phenotypes
- S-91: The impact of sleep on frailty, sarcopenia, and falls: Investigating novel risk factors in aging populations
- S-92: The impact of war on sleep: Uncovering the mechanisms that link trauma exposure and sleep quality across different cohorts and age groups
- S-93: Unveiling and addressing sleep health disparities in indigenous peoples around the world
- S-94: The link between heart rate variability, autonomic alterations, and sleep disorders across lifespan and pathologies
- S-95: No strings attached: Harnessing novel contactless technology for sleep health and beyond
- S-96: Circadian rhythm sleep-wake disorders: Relevance to behavior and comorbidity
- S-97: Obstructive sleep, apnea: Studies by early-stage investigators
- S-98: Beyond the classical pentad: Narcolepsy from a multimodal perspective
- S-99: Promoting infant sleep in different cultures: Lessons from developing, adapting and evaluating innovative sleep interventions for infants in various cultures
- S-100: The rhythm of rest: Exploring the cognitive and psychological benefits and drawbacks associated with intraindividual variability in sleep
- S-101: ISSS symposium: The role of anatomic surgery in adult sleep apnea patients failing conventional treatments: Latest evidence and guidelines
- S-102: Digital advancements in oral appliance therapy for obstructive sleep apnea
- S-103: Cardiovascular implications of sleep disruption in women: Emerging evidence and clinical implications
- S-104: Shaping the future of sleep medicine: Evidence, innovations, and insights from Sleep Revolution
- S-105: Waking up the workforce: Exploring the impact of sleep on workplace performance, decision-making, and outcomes
- S-106: World clock: Turning back time on diagnostic delays in NT1
- S-107: Beyond scoring: Transforming sleep medicine with AI
- S-108: Sleep, sleep apnea, and heart rhythm: All you can learn
- S-109: Examining sleep contributions to pathways from stress to affective psychopathology in children and youth
- S-110: Chrononutrition to optimize health
- S-111: Translation of endo-phenotyping of adult obstructive sleep apnea to the clinic
- S-112: Targeting sleep disturbances in mental disorders: Does it make the difference?
- S-113: The mind throughout the sleep-wake cycle: The importance of cognitive phenomenology in sleep clinics
- S-114: New insights on the control of breathing during sleep and innovative genetic approaches for obstructive sleep apneas
- S-115: Sleep in athletes and the application to occupational settings
- S-116: The role of sleep and circadian factors for motivation and behavior
- S-117: Artificial intelligence approaches to physiologic signals in sleep medicine
- S-118: The molecular link between sleep and neurodevelopment
- S-119: Empowering women's sleep health through artificial intelligence
- S-120: Sleep and long COVID: From epidemiology to future prevention on behalf of Second International COVID-19 Sleep Study (ICOSS-II) group
- S-121: Novel sleep intervention trials for enhancing brain health across the lifespan
- S-122: Children's sleep in context: The role of social, economic, and educational policy and practice in early sleep development
- S-123: The waking nightmare: Unraveling the evidence behind the intertwined pathways between sleep and cancer
Oral Abstract Sessions
- O-01: Advancing surgical and neurostimulation therapies for obstructive sleep apnea
- O-02: Orexin-based therapies and pharmacological advances in narcolepsy
- O-03: Sleep health trajectories in childhood and adolescence
- O-04: Basic Science: Sleep deprivation and sleep disorder
- O-05: Optimizing therapeutic strategies and outcomes in obstructive sleep apnea management
- O-06: Innovations in the diagnosis and management of RLS
O-07: Dental and surgical sleep medicine interactions(Session Not Available)- O-08: Light and sleep health
- O-09: Targeting the orexin pathway: Emerging pharmacotherapies for narcolepsy type 1
- O-10: Novel approaches to treating insomnia
- O-11: Sleep in childhood and adolescence
- O-12: Basic research: Animal models of sleep and sleep disorder
- O-13: New sensing or signal analysis methods in sleep
- O-14: Sleep and circadian regulation of cognition and memory
- O-15: Psychiatric disorders affecting wake / sleep
- O-16: Sleep and aging brains: Patterns, risks, and predictive insights
- O-17: Biomarkers, phenotyping, and cognitive aspects in narcolepsy and hypersomnolence
- O-18: Tracking sleep: Tools, trends, and tailored interventions
- O-19: New Investigator Award
O-20: Sleep and sleep deprivation neurophysiology(Session Not Available)- O-21: Phenotyping and variability in obstructive sleep apnea: Implications for cardiovascular risk and personalized management
- O-22: The science of sleep health: Biomarkers, behavior, and big data
- O-23: Neurophysiological signatures and technological innovations in sleep apnea detection and impact assessment
O-24: Treatment and risk factor modifications in circadian rhythm disorders(Session Not Available)- O-25: Biomarkers and neuroimaging in prodromal RBD and synucleinopathies
- O-26: Infant and preschool sleep: Patterns and problems
- O-27: Rethinking daytime sleepiness: Multimodal approaches to identification and management
- O-28: Chronobiology and neurophysiology in early neurodegeneration
- O-29: Pediatric sleep-disordered breathing: Diagnostic innovation, biological mechanisms, and therapeutic strategies in complex and vulnerable populations
- O-30: Sleep and public health: Stress, climate, and community
- O-31: Management of insomnia with digital CBT-I
- O-32: Pathophysiological and diagnostic advances in RBD and NREM parasomnias
- O-33: Multisystem pathophysiology and biomarker discovery in sleep apnea
- O-34: Mechanisms and modulation of sleep-related cognitive dysfunction
- O-35: Novel sleep technology approaches with clinical applications
- O-36: Neurophysiology of sleep and cognitive aging
- O-37: Symptomatology, phenotypes, and pathophysiology of insomnia
-
Register
- Non-member - $900
- Regular Member - $450
- Student Member - $450
- Technician Member - $450
- More Information
-
Contains 1 Component(s)
Industry Session presented at World Sleep 2025 in Singapore.
Industry Session presented at World Sleep 2025 in Singapore.
Managing insomnia disorder in patients with neurological and psychiatric comorbidities
The impact of insomnia disorder for patients
David Neubauer
United StatesNew clinical data on daridorexant for managing insomnia disorder
Atul Khullar
CanadaClinical experience managing insomnia disorder in patients with psychiatric comorbidities
Laura Palagini
ItalyClinical experience managing insomnia disorder in patients with neurological comorbidities
Claudio Liguori
ItalySupported by Idorsia Pharmaceuticals Ltd.
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Register
-
Contains 27 Product(s)
Open-access sessions from World Sleep 2025 in Singapore. Log into your free World Sleep Society account to view!
After registering for the bundle, navigate to the Content tab and activate sessions of interest to add them to your dashboard.
This free bundle gives you access to the following sessions from World Sleep 2025 in Singapore:
Keynotes
- K-01: Thomas Penzel: Innovations in sleep technology: Advancing diagnosis and treatment of sleep disorders
- K-08: Célyne Bastien: Sleep misperception: A waking perspective
- K-12: Joshua J. Gooley: The hard facts supporting later learning start times
Symposia
- S-04: WSS Task Force recommendations for use of consumer health trackers for sleep tracking
- S-07: Hypersomnolence in focus: Orexin as the key to treating comorbidities and secondary diseases?
- S-12: Narcolepsy: Examining the science, impact, and current unmet needs
- S-13: World Health Organization report on road safety: Pathway to global professional driver work hours regulations
- S-18: iRBD biomarkers through the lens of young scientists: What do we have and what do we need?
- S-25: Open data and open science in sleep medicine and sleep research
- S-40: Best of SLEEP MEDICINE – Journal Highlights 2025
- S-69: Discussion group: Global perspectives on sleep health advocacy: Insights and experiences across five continents
- S-85: Consumer sleep technology: Usefulness and reliability for patients and practitioners
- S-120: Sleep and long COVID: From epidemiology to future prevention on behalf of Second International COVID-19 Sleep Study (ICOSS-II) group
Oral Abstract Sessions
- O-02: Orexin-based therapies and pharmacological advances in narcolepsy
- O-04: Basic Science: Sleep deprivation and sleep disorder
- O-09: Targeting the orexin pathway: Emerging pharmacotherapies for narcolepsy type 1
- O-10: Novel approaches to treating insomnia
- O-13: New sensing or signal analysis methods in sleep
- O-19: New Investigator Award
- O-30: Sleep and public health: Stress, climate, and community
Courses
Industry Sessions
- Bayer: Sleep disturbance across menopause - innovations in measurement and treatment
- Narcolepsy Group Workshop with Takeda
- Nox Medical: Precision Breathing: Advancing Sleep Apnea Phenotyping Through Accurate Flow Measurement
- ProSomnus: Beyond Mandibular Advancement: Science, Innovation and Outcomes
- Resmed: OSA Underdiagnosis- A world of difference, a common challenge
- Idorsia: Managing insomnia disorder in patients with neurological and psychiatric comorbidities
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information